# Dolutegravir in Real Life in Lesotho

> **NCT04238767** · — · COMPLETED · sponsor: **Swiss Tropical & Public Health Institute** · enrollment: 1433 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **DRUG:** Dolutegravir

## Key facts

- **NCT ID:** NCT04238767
- **Lead sponsor:** Swiss Tropical & Public Health Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-10
- **Primary completion:** 2021-05-19
- **Final completion:** 2021-05-20
- **Target enrollment:** 1433 (ACTUAL)
- **Last updated:** 2023-05-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04238767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04238767, "Dolutegravir in Real Life in Lesotho". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04238767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*